Global and China Nicotine Gum Market Insights, Forecast to 2027

Nicotine gum is a smoking cessation product that helps smokers to slowly overcome nicotine addiction. Nicotine is released by chewing the gum and is absorbed into the blood stream through the lining of the mouth, which helps smokers to slowly reduce their craving for nicotine. It is one of nicotine replacement therapies (NRT’s) and it is an over-the-counter medication.
The nicotine gum is available in various dosages and can be consumed according to the level of addiction.
The major players in global Nicotine Gum market include GSK, Johnson & Johnson, Perrigo Company, etc. The top 3 players occupy about 65% shares of the global market. Europe is the largest market, with a share over 40%, followed by North America and Asia-Pacific. In terms of product, 2 mg Nicotine Gum is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Individual Smokers, followed by Withdrawal Clinics, Medical Practice, etc.

Market Analysis and Insights: Global and China Nicotine Gum Market
This report focuses on global and China Nicotine Gum market.
In 2020, the global Nicotine Gum market size was US$ 372 million and it is expected to reach US$ 567 million by the end of 2027, with a CAGR of 6.3% during 2021-2027. In China the Nicotine Gum market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Nicotine Gum Scope and Market Size
Nicotine Gum market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nicotine Gum market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Nicotine Gum market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
2 mg Nicotine Gum
4 mg Nicotine Gum
6 mg Nicotine Gum

Segment by Application
Withdrawal Clinics
Medical Practice
Individual Smokers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
GSK
Perrigo Company
Fertin Pharma
Johnson & Johnson
Biophore (Zenara)
Alkalon A/S
Lucy
Dr. Reddy's Laboratories
Cipla